ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 153 filers reported holding ITEOS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,253,316 | +19.1% | 114,458 | +44.0% | 0.00% | 0.0% |
Q2 2023 | $1,052,342 | +6.4% | 79,482 | +9.4% | 0.00% | 0.0% |
Q1 2023 | $988,984 | -24.4% | 72,666 | +8.4% | 0.00% | 0.0% |
Q4 2022 | $1,308,764 | -19.9% | 67,013 | -21.8% | 0.00% | -50.0% |
Q3 2022 | $1,633,000 | +133.0% | 85,745 | +152.1% | 0.00% | +100.0% |
Q2 2022 | $701,000 | +164.5% | 34,006 | +339.2% | 0.00% | – |
Q1 2021 | $265,000 | +31.2% | 7,742 | +29.4% | 0.00% | – |
Q4 2020 | $202,000 | – | 5,983 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |